Whilst the results read ok its not exactly a large trial with only 12 patients and they only take BIT225 for 28days whilst they are mainly on IFN/RBV over the 48 weeks. Why isnt BIT225 the main drug.
Whilst they all benefited after 24weeks only information from a subset benefited up to 48weeks , does it mean only a subset of patients and not all benefited out to 48weeks.
"12 patients received IFN/RBV for 7 days before
commencing treatment with BIT225. They then received 300 mg BIT225 twice daily plus IFN/RBV
for 28 days. After that time, patients continued to take IFN/RBV for 48 weeks"
"All HCV genotype 3 patients completing treatment are virus-free at 24 weeks
? Preliminary data from subset of patients shows benefit extends out to 48 weeks"
If there is anything in all this expect a large cap raising with broker support as under $1m left in kitty come the quarter close.
- Forums
- ASX - By Stock
- BIT
- sit tight on your biotron shares
sit tight on your biotron shares, page-17
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.85M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.2¢ | $20.69K | 940.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 537628 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 141604 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 537628 | 0.021 |
8 | 454100 | 0.020 |
10 | 1899381 | 0.019 |
7 | 234054 | 0.018 |
4 | 408000 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 141604 | 1 |
0.024 | 439576 | 4 |
0.025 | 600000 | 3 |
0.026 | 53847 | 1 |
0.027 | 162000 | 2 |
Last trade - 15.51pm 28/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |